Skeptic Ginger
Nasty Woman
- Joined
- Feb 14, 2005
- Messages
- 96,955
Given that all of SARS, MERS and Covid-19 mutated recently to enable human - human transmission, it's not that big a leap to say it could mutate again.
That's a single mutation or two that makes a virus better bind to human cells.
It's not the same as the continual genetic drift of influenza.
I'm not saying drug resistance won't develop, but the two viruses don't have the same mutation rate.
Journal of Virology: Viral Mutation Rates discusses the differences in viruses in general.
BMC Evolutionary Biology - Moderate mutation rate in the SARS coronavirus genome and its implications
The estimated mutation rates in the SARS-CoV using multiple strategies were not unusual among coronaviruses and moderate compared to those in other RNA viruses. ...
... Therefore the mutation rate was placed in the range of 0.80 – 2.38 × 10-3 nucleotide substitution per site per year based on the 11 sequences used.
Table of other virus mutation rates.
The higher range is close to influenza but not the lower estimate.
Further evaluation of the current circulating strain with a lot more genome analyses:
Live Science - How fast can the coronavirus mutate? (First part discusses the L and S strains and premature conclusions about one being milder than the other.)
So, what does all of this mean for the development of a possible vaccine?
These viruses "are still so genetically similar that these mutations shouldn't alter a new vaccine," Grubaugh said. It's "unlikely that the developers have to worry about this." Once the vaccine is out, however, the virus could adapt to it and develop resistance, he said, but considering that other RNA viruses — such as those that cause measles, mumps and yellow fever — didn't develop resistance to vaccines, that scenario is unlikely.
Last edited: